Covered recipient · General Payments record
LARRY C DANIELS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2022
$824.15
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $167.83 | 9 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $70.97 | 3 |
| Lilly USA, LLC | $45.31 | 3 |
| Xeris Pharmaceuticals, Inc. | $36.41 | 2 |
| Acerta Pharma LLC | $15.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $15.14 | 03/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 914663055 | CMS |
| Lilly USA, LLC | $18.25 | 03/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918112027 | CMS |
| Lilly USA, LLC | $14.95 | 06/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918119925 | CMS |
| Lilly USA, LLC | $12.11 | 11/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918151405 | CMS |
| Teva Pharmaceuticals USA, Inc. | $23.93 | 06/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954911311 | CMS |
| Teva Pharmaceuticals USA, Inc. | $30.23 | 07/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954911029 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.81 | 07/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954911037 | CMS |
| Xeris Pharmaceuticals, Inc. | $20.63 | 08/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 946482819 | CMS |
| Xeris Pharmaceuticals, Inc. | $15.78 | 09/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 946482821 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.